Park Medi World Ltd (PARKHOSPS) Q1 FY27 Results Analysis: PAT Jumps 42%, EBITDA Margin Contracts 115 bps

Park Medi World Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 475.71 Cr (+19.27% YoY) and PAT growth of +35.23% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

Revenue grew 19.3% YoY with PAT to owners up 42.3% YoY, and PAT margin of 18.62% exceeded the guided range. However, EBITDA margin contracted 115 bps QoQ due to Panchkula ramp-up, and near-term margin pressure from new hospital additions is expected. The company remains on track for its FY27 margin guidance.

Key Investment Insights

Key Positives

• Revenue grew 19.3% YoY to Rs.475.71 Cr, fifth consecutive quarter of double-digit growth.
• PAT attributable to owners grew 42.3% YoY to Rs.82.51 Cr.
• PAT margin of 18.62% exceeded the guided range of 15-17%.
• Finance costs declined 35.2% YoY to Rs.9.81 Cr due to near-debt-free balance sheet.
• Material costs as a percentage of revenue improved 133 bps YoY.
• New bed capacity expanded from ~3,610 to ~3,960 with Panchkula commissioning.

Risk Factors

• EBITDA margin contracted 115 bps QoQ to 26.51% due to Panchkula initial ramp-up drag.
• New hospital ramp-up (Panchkula, upcoming Rudrapur, Zirakpur) expected to keep margins in lower half of guided band near term.
• Other expenses as a percentage of revenue rose 39 bps YoY.
• Effective tax rate dropped to 15.69% due to deferred tax benefit of Rs.9.34 Cr, which may not recur.